The primary endpoint will be the number of CD8 + cells ( cell counts per mm2 ) in bronchial biopsy tissue specimens ( sub-mucosa ) and the key secondary endpoint will be the number of CD68 + cells ( cell counts per mm2 ) , assessed by indirect immunohistochemistry .